August 2010 Volume 6, Issue 8

Volume 6, Issue 8 | August 2010

August 2010

In this Issue

Global News

Drug Discovery News Placeholder Image

A pain-free alliance

Servier and Galapagos initiate strategic alliance in osteoarthritis
Drug Discovery News Placeholder Image

That’s Italian

Aptuit to acquire operations at GSK’s Medicines Research Centre in Verona
Drug Discovery News Placeholder Image

The potential of Polish science

Selvita and Orion collaborate on Alzheimer’s disease program
Drug Discovery News Placeholder Image

From the Buckeye State to Beijing

BioOhio, Beijing Pharma forge international biomedical, business partnership

Commentary

Drug Discovery News Placeholder Image

The role of nanoemulsions in vaccines, adjuvants, anti-infectives and dermatological treatments

The pharmaceutical industry continues to struggle with bringing new, commercially viable therapies to market.
Drug Discovery News Placeholder Image

Where will innovation come from?

In the early 1980s, I traveled to Berlin and to China for the first time. To reach Berlin, you flew in a PanAm DC-9 from Frankfurt, your only choice of airline and departure airport. It was a beautiful day. Crossing the border to East Germany, many things disappeared: color, highways, modern buildings and traffic. From low altitudes, it appeared that 30 to 40 years had just been lost.

Editor's Focus

Drug Discovery News Placeholder Image

ddn dissects current cancer craze

Business deals and agreements associated with cancer research are plentiful these days, and this month, ddn’s editors and writers give you several examples of the latest oncology-related acquisitions, mergers and partnerships to be signed in this burgeoning area of pharmaceutical and biological research.

Research & Development

Drug Discovery News Placeholder Image

Celgene reaches into deep pockets again

Enticed by tumor drug, Celgene acquires Abraxis BioScience for nearly $3 billion upfront and up to $650 million if certain goals are met
Drug Discovery News Placeholder Image

Getting under their skin

Valeant and Biovail agree to merge, creating leader in dermatology and neurology pharmaceuticals
Drug Discovery News Placeholder Image

sanofi-aventis continues R&D spending spree

French pharma acquires U.S. biopharmaceutical firm TargeGen for $75 million
Drug Discovery News Placeholder Image

Lilly acquisition blossoms

Company to pay as much as $380 million for Alnara
Drug Discovery News Placeholder Image

Fail-safe product and deal

Option agreement between Cadence Pharmaceuticals and Incline Therapeutics gives Cadence two option periods to acquire Incline

Instruments & Informatics

Drug Discovery News Placeholder Image

Human genomics for the masses

Roche and IBM collaborate on nanopore-based DNA sequencing technology with eyes toward advancing personalized healthcare
Drug Discovery News Placeholder Image

Sosei to acquire Activus Pharma

Deal marks Sosei’s continued efforts to grow through non-organic means
Drug Discovery News Placeholder Image

Picking up the slack … and then some

Eurofins MWG Operon and Genomatix join forces to offer advanced NGS
Drug Discovery News Placeholder Image

Getting a signal

Promega, SignalChem to offer complete kinase solutions

Omics & Systems Biology

Drug Discovery News Placeholder Image

Multimillion miRNA deal

sanofi-aventis, Regulus form strategic alliance in microRNA therapeutics
Drug Discovery News Placeholder Image

Boosting R&D with a little M&A

Gilead Sciences acquires CGI Pharmaceuticals and adds numerous small- molecule kinase inhibitor compounds to its pipeline
Drug Discovery News Placeholder Image

A class of their own

Santaris Pharma, miRagen Therapeutics to develop microRNAs for treatment of cardiovascular disease
Drug Discovery News Placeholder Image

Pushing the limits of phosphoproteomics

Purdue University researcher patents new retrieval method that makes studying cancer proteins easier
Drug Discovery News Placeholder Image

Ariadne’s thread of connections

Bioinformatics company to collaborate in multimillion-dollar EU-based neuromuscular disease consortium to find biomarkers

Contract Services

Drug Discovery News Placeholder Image

Back to the future with Parkinson’s research

Michael J. Fox Foundation partners with leading CROs to develop biomarker candidates for Parkinson’s disease
Drug Discovery News Placeholder Image

Changing the channel

Milestone-driver collaboration between Essen BioScience and Nycomed boosts ion-channel drug discovery
Drug Discovery News Placeholder Image

A gem of a partnership

Emerald BioStructures, FORMA Therapeutics partner to develop treatments for lymphoma and other cancers
Drug Discovery News Placeholder Image

Going for prime time

Quintiles inks deal with University Malaya Medical Center in Malaysia

Diagnostics

Drug Discovery News Placeholder Image

TRANSCENDing a typical partnership

MIT’s Koch Institute collaborates with Ortho-McNeil-Janssen and affiliates in oncology R&D
Drug Discovery News Placeholder Image

A personal touch for cancer therapy

Aeterna Zentaris to collaborate with Almac on therapy and companion diagnostic in multiple oncology targets
Drug Discovery News Placeholder Image

Signed on the dotted line

Signature Diagnostics to use Affymetrix microarray technology for detecting and predicting progression of colorectal cancer
Drug Discovery News Placeholder Image

Rheumatoid arthritis reprise

TcLand Expression, a spinoff of Inserm Transfert, rejoins former partner to pursue RA companion diagnostics

Special Reports

Drug Discovery News Placeholder Image

Let’s work together

Peeling back the layers of integrated approaches to oncology research
Drug Discovery News Placeholder Image

The big picture

Multiple approaches—and ultimately, more comprehensive ones—are critical to understanding and treating cancer

New Products

Drug Discovery News Placeholder Image

Automates preparation of fragment libraries

Beckman Coulter Genomics has introduced the SPRIworks Fragment Library System II.
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

GreenCooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
Clear sample tubes are shown in a clear tote with red lids in a sample prep robot with a blue and silver industrial lab background.

The crucial role of sample preparation in biotherapy manufacturing

Discover how better sample preparation can unlock improved assay accuracy and analytical results.
A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue